227 related articles for article (PubMed ID: 25641551)
1. Personalised medicine in veterinary oncology: one to cure just one.
Klopfleisch R
Vet J; 2015 Aug; 205(2):128-35. PubMed ID: 25641551
[TBL] [Abstract][Full Text] [Related]
2. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
[TBL] [Abstract][Full Text] [Related]
3. Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers.
Wang G; Wu M; Durham AC; Mason NJ; Roth DB
Vet Comp Oncol; 2022 Mar; 20(1):91-101. PubMed ID: 34286913
[TBL] [Abstract][Full Text] [Related]
4. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
[TBL] [Abstract][Full Text] [Related]
5. Towards the Delivery of Precision Veterinary Cancer Medicine.
Katogiritis A; Khanna C
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):809-818. PubMed ID: 31256903
[TBL] [Abstract][Full Text] [Related]
6. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
[TBL] [Abstract][Full Text] [Related]
7. Personalised cancer medicine.
Jackson SE; Chester JD
Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
[TBL] [Abstract][Full Text] [Related]
8. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary.
Yates LR; Seoane J; Le Tourneau C; Siu LL; Marais R; Michiels S; Soria JC; Campbell P; Normanno N; Scarpa A; Reis-Filho JS; Rodon J; Swanton C; Andre F
Ann Oncol; 2018 Jan; 29(1):30-35. PubMed ID: 29140430
[TBL] [Abstract][Full Text] [Related]
9. Mining the fecal proteome: from biomarkers to personalised medicine.
Jin P; Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2017 May; 14(5):445-459. PubMed ID: 28361558
[TBL] [Abstract][Full Text] [Related]
10. [Personalised medicine. Aims and challenges].
Bieber T; Broich K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
[TBL] [Abstract][Full Text] [Related]
11. Veterinary oncology: Biology, big data and precision medicine.
Pang LY; Argyle DJ
Vet J; 2016 Jul; 213():38-45. PubMed ID: 27240913
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine in Veterinary Science.
Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
[TBL] [Abstract][Full Text] [Related]
13. [Personalised medicine. Paradigm shift within drug research and therapy].
Stock G; Sydow S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1495-501. PubMed ID: 24170078
[TBL] [Abstract][Full Text] [Related]
14. Genomic and proteomic profiling for cancer diagnosis in dogs.
Morris JS
Vet J; 2016 Sep; 215():101-9. PubMed ID: 26848120
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing in precision oncology: challenges and opportunities.
Kruglyak KM; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing and empowering personalised cancer medicine.
McDermott U
Drug Discov Today; 2015 Dec; 20(12):1470-5. PubMed ID: 26494142
[TBL] [Abstract][Full Text] [Related]
17. Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients.
Hernandez-Martinez JM; Sánchez-Reyes R; De la Garza-Salazar JG; Arrieta O
Adv Exp Med Biol; 2019; 1168():79-90. PubMed ID: 31713165
[TBL] [Abstract][Full Text] [Related]
18. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
Blumenthal GM; Mansfield E; Pazdur R
JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
[No Abstract] [Full Text] [Related]
19. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
[TBL] [Abstract][Full Text] [Related]
20. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.
Brennan DJ; Kelly C; Rexhepaj E; Dervan PA; Duffy MJ; Gallagher WM
Cancer Genomics Proteomics; 2007; 4(3):121-34. PubMed ID: 17878516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
